Molecular Vision 2013; 19:935-943 <http://www.molvis.org/molvis/v19/935>
Received 26 June 2012 | Accepted 26 April 2013 | Published 30 April 2013

A novel forkhead box C1 gene mutation in a Korean family with Axenfeld-Rieger syndrome

Gyu-Nam Kim,1 Chang-Seok Ki,3 Seong-Wook Seo,1,2 Ji-Myong Yoo,1,2 Yong-Seop Han,1,2 In-Young Chung,1,2 Jong-Moon Park,1,2 Seong-Jae Kim1,2

The first two authors contributed equally to this work

1Department of Ophthalmology, Gyeongsang National University, College of Medicine, Jinju, Korea; 2Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Korea; 3Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence to: Seong-Jae Kim, Department of Ophthalmology, School of Medicine, Institute of Health Science, Gyeongsang National University, Jinju, Gyeongnam 660-751, S. Korea; Phone: +82-55-750-8170; FAX: +82-55-758-4158; email: maya12kim@naver.com

Abstract

Purpose: To report a case series of patients with novel forkhead box CI (FOXC1) mutations in a Korean family with Axenfeld-Rieger syndrome (ARS).

Methods: Four members of the same family underwent complete ophthalmologic and systemic examinations and genetic analysis. Genomic DNA was isolated from peripheral blood leukocytes, and all coding exons with flanking intronic regions of the FOXC1 and pituitary homeobox 2 genes were amplified using PCR, and sequenced.

Results: The patients were 40, 12, 11, and 10 years old (father, son, and two sisters, respectively). All four had uncontrolled intraocular pressure, glaucomatous visual field defect, retinal nerve fiber layer defect, iridocorneal adhesion on gonioscopy, hypoplasia and marked atrophy of the iris, flattening of the midface, and broad flat noses. A diagnosis of ARS was made based on characteristic ocular and systemic traits. A novel FOXC mutation, c.317delA, was identified in all affected members of the family with ARS.

Conclusions: We found a novel c.317delA mutation in FOXC1 in a Korean family with ARS. We suggest that this FOXC1 mutation causes typical ARS, and that our results may be useful for better understanding of the spectrum of FOXC1 mutations and the role of FOXC1 in the development and progression of ARS.

Introduction

Axenfeld-Rieger syndrome (ARS) is characterized by anomalies of the anterior segment of the eye and systemic signs, and is inherited in an autosomal dominant pattern [1]. The anterior segment anomalies include iris strands connecting the iridocorneal angle to the trabecular meshwork and a prominent, anteriorly displaced Schwalbe’s line (posterior embryotoxon), iris hypoplasia, abnormal situation of pupil (corectopia), more than one pupil in an eye (polycoria), and glaucoma [2,3]. The systemic signs include abnormality of the cardiovascular outflow tract, midface hypoplasia, a broad flat nasal root, maxillary and occasionally mandibular hypoplasia, hypertelorism (excessive distance between two eyes) and telecanthus (abnormally increased distance between the medial canthi of the eyelids), microdontia (abnormally small teeth), hypodontia (having fewer teeth than normal), skeletal anomalies, and hearing loss. The phenotype of this syndrome varies considerably among cases and even in the two eyes of the same individual [2,4,5].

ARS is genetically heterogenous, and two major genes, forkhead box C1 (FOXC1) on chromosome 6p25 and pituitary homeobox 2 (PITX2) on chromosome 4q25, have been demonstrated to cause the disease [6,7]. The FOXC1 mutation is more likely to be associated with glaucoma, while the risk of systemic abnormalities is greatest with the PITX2 mutation. Other implicated loci include those at 13q14 and 16q24, but no definitively causative mutations have been identified in any one gene. A recent, single autosomal recessive case of a child with characteristic anterior chamber anomalies and umbilical hernia was identified as a compound heterozygote for mutations in CYP1B1 [8-10].

The FOXC1 gene is a member of the forkhead family of transcription factors, which play important roles in embryogenesis, tissue-specific gene expression, and tumor development. FOXC1 recognizes and binds to specific DNA sequences through the conserved 110-amino-acid forkhead domain (FH), and thus activates the target genes [11]. The most common FOXC1 defects leading to ARS are point mutations. More than 40 documented deletions, either interstitial or telomeric, involve 6p25, and patients frequently present with ocular, craniofacial, skeletal, and cardiac malformations and hearing loss. The phenotypic variation seen in these patients is largely due to the size of the deletions and the genes involved [12-14]. To the best of our knowledge, intragenic mutations, including deletions, of FOXC1 have been described in 46 patients, but c.317delA has not been detected in any patients with ARS, including those with ocular and systemic abnormalities [15]. Here, we describe the c.317delA genetic aberration in a Korean family and the clinical phenotypes of ARS in these patients.

Methods

The purpose of the study and the procedures were explained to all patients, and informed consent was obtained. The procedures used conformed to the tenets of the Declaration of Helsinki. This study was approved by the Gyeongsang National University Institutional Review Board. The proband (Figure 1A) in this Korean family was a 12-year-old boy who presented with decreased visual acuity and intraocular pressure (IOP) uncontrolled by antiglaucoma medications in the right eye. His best-corrected vision was 20/200 in the right eye and 20/20 in the left eye. The IOP measured with Goldmann applanation tonometry was 36 mmHg in the right eye and 24 mmHg in the left. Ocular examination revealed normal corneal diameter, Haab’s striae (horizontal break in Descemet’s membrane), and iris atrophy in both eyes. In addition, gonioscopy showed open angles in both eyes with anterior insertion of the iris into the trabecular meshwork with prominent iris processes. He had apparent hypertelorism, telecanthus, a flat face, and a flat, broad nasal bridge. Because of these findings, he was diagnosed with bilateral ARS.

This family had four affected members: the proband, his father, and his two younger sisters (Figure 1A). Table 1 summarizes the clinical characteristics of the ocular and systemic examination of the four patients in this family.

Clinical evaluation

All four patients underwent comprehensive ophthalmologic examinations, including best-corrected visual acuity measurement and slit lamp biomicroscopy, followed by ophthalmoscopy after pupillary dilation. Additional examinations included anterior segment photography, gonioscopic photography, optical coherence tomography (Carl Zeiss Meditec, Dublin, CA), visual field testing (Carl Zeiss Meditec), dental panoramic radiography, trans-thoracic echocardiography, auditory function testing, and computed tomography of the head. In addition, we obtained information about the patients’ systemic abnormalities through the clinical interview.

Mutation analysis of the pituitary homeobox 2 and forkhead box C1 genes

Genomic DNA was isolated from peripheral blood leukocytes using the Wizard Genomic DNA Purification Kit (Promega, Madison, WI). All coding exons, with flanking intronic regions, of the FOXC1 and PITX2 genes were amplified using PCR with primers designed by the authors (available upon request) and a thermal cycler (Model 9700; Applied Biosystems, Foster City, CA). Sequencing was performed with the ABI Prism 3100×l Genetic Analyzer (Applied Biosystems) using the BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems). The obtained sequences were analyzed using Sequencher software (version 4.10.1, Gene Codes, Ann Arbor, MI) and compared with the reference sequence for FOXC1 (NM_001453.2) and PITX2 (NM_000325.5). We followed the Human Genome Variation Society guidelines to describe sequence variations: “A” of the ATG translation start site was numbered +1 for the DNA sequence, and the first methionine was numbered +1 for the protein sequence.

Results

Molecular genetic analysis of the forkhead box C1 and pituitary homeobox 2 genes

The proband presented with complex bilateral anterior segment developmental anomalies including the presence of Haab’s striae (see “Patient Details”; Figure 2). The father and sisters of the proband showed a typical ARS phenotype, but the proband’s mother appeared normal, with no sign of the disease. We screened the four members of the family for coding mutations in the FOXC1 and PITX2 genes. The proband was heterozygous for a 1-bp deletion in the FOXC1 gene (c.317delA) that is expected to result in ARS through haploinsufficiency either due to nonsense-mediated decay of mutant mRNA or mutant FOXC1 protein produced with 181 amino acids rather than full-length 553 amino acids missing the forkhead domain, the most important function part of the protein (p.Gln106Argfs*75, Figure 1B,C). Analysis of the parents revealed that this mutation was inherited from the proband’s father, since the mother had a wild-type sequence. The two affected sisters of the proband had the same variant as their father and brother. When we tested 104 unaffected ethnically matched controls, none had the mutation. In addition, no sequence variant was found in the PITX2 gene.

Clinical characteristics

Clinical evaluation of the four patients showed typical clinical phenotypes of ARS, including uncontrolled intraocular pressure, glaucomatous visual field defect, iridocorneal adhesion on gonioscopy, hypoplasia and marked atrophy of the iris, flattening of the midface, and broad, flat noses. Interestingly, in these four patients, who had glaucoma in both eyes, the eye with more extensive areas of anterior insertion of the iris into the trabecular meshwork with prominent iris processes presented with higher IOP and was more resistant to medical treatment, to the point that two of the patients needed surgical management. In addition, of both eyes affected by ARS, the eye with higher IOP presented a thicker central cornea with broad Haab’s striae and lower endothelial cell counts. These asymmetric ocular manifestations were identified in the early stages and the later stages of the disease in this family. None of the four patients had any abnormalities on dental panoramic radiograph, auditory function test, trans-thoracic echocardiography, or computed tomography of the head.

Patient details

Patient I:1-- A 40-year-old man was referred to our clinic because of uncontrolled IOP in the right eye. He was a known patient with glaucoma and had been treated by topical antiglaucoma medications in both eyes. However, he had been completely blinded in his left eye because of glaucoma 10 years earlier. He was referred to our center for IOP uncontrolled by topical medications in the right eye for 1 year. IOP measured with Goldmann tonometry was 26 mmHg in the right eye and 36 mmHg in the left. His best-corrected vision was 20/80 in the right eye with mild myopia. His left eye was deviated outward. Slit lamp examination revealed slight corneal edema, Haab’s striae, iridocorneal adhesions, and atrophy of the iris with corectopia in both eyes. Further physical examination revealed a flat midface, hypertelorism, and telecanthus. Other detailed ocular and systemic findings for this patient are shown in Table 1 and Figure 3. He had normal intelligence. Based on these findings, he was diagnosed with ARS. The IOP in the right eye was not adequately controlled with medication alone, so we performed trabeculectomy with mitomycin C in this eye. Postoperatively, at the third month, the IOP was well controlled in the right eye.

Patient II:1-- A 12-year-old boy was referred to our clinic because of uncontrolled IOP in the right eye. He was born at 38 weeks' gestation with a birthweight of 2,500 g. The pregnancy and delivery were uneventful. The corneal diameter was 12 mm in both eyes. His best-corrected vision was 20/200 in the right eye and 20/20 in the left eye. IOP measured with Goldmann tonometry was 36 mmHg in the right eye and 24 mmHg in the left. Haab’s striae and iris hypoplasia were seen in the anterior segment. Gonioscopy showed open angles in both eyes with anterior insertion of the iris into the trabecular meshwork, prominent iris processes, and broad-based synechiae in places. Optic disc examination revealed a cup-to-disc ratio (CDR) of 0.9 in the right eye and 0.6 in the left. Humphrey visual fields revealed severe glaucomatous defects in the right eye, but the left eye was normal. The patient had apparent hypertelorism, telecanthus, a flat face, and a flat, broad nasal bridge. Other detailed ocular and systemic findings for this patient are shown in Table 1 and Figure 2. Because of these findings, he was diagnosed with bilateral ARS. He was treated with topical antiglaucoma medications in both eyes. The IOP in both eyes was well controlled on medication alone.

Patient II:2-- An 11-year-old girl was referred to our clinic because of uncontrolled IOP in the right eye. She was born at 37 weeks' gestation with a birthweight of 2,800 g. The pregnancy and delivery were uneventful. The corneal diameter was 11.8 mm in both eyes. Her best-corrected vision was 20/200 in the right eye and 20/20 in the left eye. IOP as measured with Goldmann tonometry was 32 mmHg in the right eye and 24 mmHg in the left. Iris hypoplasia and posterior embryotoxon were seen in both eyes, but Haab's striae were present only in the right eye. Gonioscopy showed open angles in both eyes, with anterior insertion of the iris into the trabecular meshwork, prominent iris processes, and broad-based synechiae in places. Optic disc examination revealed a CDR of 0.5 in the right eye and 0.3 in the left. Humphrey visual fields revealed severe glaucomatous defects in the right eye, but the left eye was normal. She had apparent hypertelorism, telecanthus, a flat face, and a flat, broad nasal bridge. Her other detailed ocular and systemic findings are shown in Table 1 and Figure 4. Because of these findings, she was diagnosed as having bilateral ARS. The IOP was not adequately controlled with medication alone in the right eye, so we performed trabeculectomy with mitomycin C in this eye. Postoperatively, at the fourth month, the IOP was well controlled in the right eye.

Patient II:3-- A 10-year-old girl was referred to our clinic because of uncontrolled IOP in the left eye. She was born at 38 weeks' gestation with a birthweight of 3,100 g. The pregnancy and delivery were uneventful. The corneal diameter was 11.5 mm in both eyes. Her best-corrected vision was 20/20 in both eyes. IOP, as measured with Goldmann tonometry, was 24 mmHg in the right eye and 30 mmHg in the left. Iris hypoplasia and posterior embryotoxon were seen in both eyes, but Haab's striae were seen only in the left eye. Gonioscopy showed open angles in both eyes with anterior insertion of the iris into the trabecular meshwork, prominent iris processes, and broad-based synechiae. Fundus examination revealed a CDR of 0.5 in the right eye and 0.5 in the left. Humphrey visual fields revealed paracentral scotoma in the left eye and a normal visual field in the right eye. She had apparent hypertelorism, telecanthus, a flat face, and a flat, broad nasal bridge. Other detailed ocular and systemic findings for this patient are shown in Table 1 and Figure 5. Because of these findings, she was diagnosed as having bilateral ARS. She was treated with topical medication in both eyes, and the IOP in both eyes was well controlled on medication alone.

Discussion

In this study, we described a novel FOXC1 gene mutation (c.317delA) that is expected to result in ARS through haploinsufficiency due to nonsense-mediated decay of mutant mRNA or the mutant FOXC1 protein produced (Figure 1B,C). Unidentified until now, the mutation was found in a Korean family affected by autosomal dominant ARS. To the best of our knowledge, deletions of FOXC1 have been described in 13 patients, but neither the c.317delA mutation nor the ocular and systemic abnormalities seen in the family comprising the present case series had yet been seen in patients with ARS [15]. These four patients demonstrated characteristic clinical phenotypes.

The conditions that comprise ARS are all inherited in an autosomal dominant pattern with high penetration. ARS is genetically heterogenous, and mutations in different genes lead to similar clinical phenotypes. ARS has been associated with mutations in two genes: PITX2 at 4q25 and FOXC1 at 6p25 [4,6,16]. A third locus was suggested by deletions in 13q14, supported by linkage analysis, but a disease-causing gene has not yet been identified [9,17]. In two isolated cases, deletion in the 16q23–q24 region and deletion of the PAX6 gene at 11p13, respectively, were related to ARS, but these findings were not supported by other studies [18]. In more than 60% of patients, the genetic defect underlying ARS is not known [19].

Genetically, point mutations in the FOXC1 gene cause ARS, and patients with the 6p25 deletion syndrome probably exhibit ARS because FOXC1 is located on chromosome 6p25 [4,7,20]. The FOXC1 gene is a member of the forkhead/winged helix family of transcription factors, which are characterized by an evolutionarily conserved DNA-binding domain and are essential for embryonic development [4,21]. The gene is expressed in human tissues, with the highest concentration in skeletal muscle, kidney, liver, and heart as well as the eyes [22]. In addition to the FOXC1 gene, defects in other genes in the deleted region may also result in the ocular and non-ocular phenotypes of patients with the 6p25 deletion syndrome [23]. Gould et al. summarized the phenotypes of patients with 6p25 deletions, showing that these patients exhibited a recognizable pattern of malformations. These malformations include hypertelorism, downslanting palpebral fissures, ARS, hearing loss, anomalies in the central nervous system, and developmental delay [13]. Manifestations of the four patients described in this case series were consistent with those of the 6p25 deletion syndrome.

To our knowledge, intragenic mutations of FOXC1 have been described in 46 patients, and these include missense (n=23) and nonsense (n=6) mutations, as well as deletions/insertions/duplications (n=17) [15]. These mutations in human FOXC1 have been associated with anterior segment dysgenesis, iris anomalies, and developmental glaucoma. Interestingly, the same FOXC1 mutation may lead to different clinical manifestations. For example, the Leu86Phe mutation led to ocular changes in one patient, but the same mutation in another patient led to several systemic abnormalities, including obesity, short stature, myocardial infarction, and dental abnormality [20,24]. Functional studies of FOXC1 missense mutations do not imply a strong correlation between the protein function and the phenotype. Strungaru et al. suggested that patients with FOXC1 duplication have a more severe prognosis for glaucoma development compared with patients with intragenic FOXC1 mutations [24]. Although FOXC1 clearly plays an important role in eye development, the complexities of this association are made evident by the lack of any conclusive genotype-phenotype correlations [25]. A better understanding of the relationship between these genetic lesions and clinical manifestations in patients with ARS would lead to better clinical management and genetic evaluation, but this relationship is complex and difficult. Individuals with FOXC1 mutations or deletions demonstrate a spectrum of phenotypic consequences, including the same mutated allele seen in affected and unaffected members of the same family [26,27]. It has therefore been suggested that either environmental factors and/or modifier genes interact with FOXC1 in producing a disease phenotype, and this has been seen with other ocular developmental genes [28,29]. This report is especially worthy of notice in that it showed different stages of ARS in a family.

The major clinical concern in ARS is the risk of developing sight-threatening glaucoma, which is estimated to occur in 50% of patients with ARS [2,30]. Further, only 18% of patients with glaucoma and either FOXC1 or PITX2 genetic defects respond to medical or surgical treatment [24]. Although physical occlusion of the angle structure is not a prerequisite for elevated IOP and glaucoma in ARS, the severity of glaucoma correlates with the level of iris insertion into the angle [30]. In the four patients of this series, who had glaucoma in both eyes, the eye with more extensive areas of angle closure presented with higher IOP and was more resistant to medical treatment. In addition, as shown in Figure 1, Figure 2, Figure 3, and Figure 4, the eye with higher IOP presented a thicker central cornea with broad Haab’s striae. Further functional studies may clarify whether the novel mutation of FOXC1 found in our patients is associated with an increase in the thickness of the cornea or the formation of Haab’s striae.

In summary, this study described a novel mutation (c.317delA) in the FOXC1 gene of four members of a Korean family who were affected by autosomal dominant ARS. All four patients with this until-now unidentified mutation demonstrated typical clinical phenotypes of ARS, including uncontrolled intraocular pressure, glaucomatous visual field defects, iridocorneal adhesion on gonioscopy, hypoplasia and marked atrophy of the iris, flattening of the midface, and broad, flat noses. Additionally, of both eyes affected by ARS, the eye with higher IOP presented more extensive areas of areas of anterior insertion of the iris into the trabecular meshwork with prominent iris processes and a thicker central cornea with broad Haab’s striae. We therefore suggest that the c.317delA mutation in FOXC1 is a cause of typical ARS. Our results may be useful for a better understanding of the spectrum of FOXC1 mutations and the role of FOXC1 in the development and progression of ARS. In addition, identifying the genetic causes underlying ARS cases allows for more precise genetic counseling and better prognosis. In addition, in the future, gene-specific or mutation-specific therapies may become available.

References

  1. Fitch N, Kaback M. The axenfeld syndrome and the rieger syndrome. J Med Genet. 1978; 15:30-4. [PMID: 416212]
  2. Alward WL. Axenfeld-rieger syndrome in the age of molecular genetics. Am J Ophthalmol. 2000; 130:107-15. [PMID: 11004268]
  3. Amendt BA, Semina EV, Alward WL. Rieger syndrome: A clinical, molecular, and biochemical analysis. Cell Mol Life Sci. 2000; 57:1652-66. [PMID: 11092457]
  4. Nishimura DY, Swiderski RE, Alward WL, Searby CC, Patil SR, Bennet SR, Kanis AB, Gastier JM, Stone EM, Sheffield VC. The forkhead transcription factor gene fkhl7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet. 1998; 19:140-7. [PMID: 9620769]
  5. Honkanen RA, Nishimura DY, Swiderski RE, Bennett SR, Hong S, Kwon YH, Stone EM, Sheffield VC, Alward WL. A family with axenfeld-rieger syndrome and peters anomaly caused by a point mutation (phe112ser) in the foxc1 gene. Am J Ophthalmol. 2003; 135:368-75. [PMID: 12614756]
  6. Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, Siegel-Bartelt J, Bierke-Nelson D, Bitoun P, Zabel BU, Carey JC, Murray JC. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, rieg, involved in rieger syndrome. Nat Genet. 1996; 14:392-9. [PMID: 8944018]
  7. Mirzayans F, Gould DB, Heon E, Billingsley GD, Cheung JC, Mears AJ, Walter MA. Axenfeld-rieger syndrome resulting from mutation of the fkhl7 gene on chromosome 6p25. Eur J Hum Genet. 2000; 8:71-4. [PMID: 10713890]
  8. Lines MA, Kozlowski K, Kulak SC, Allingham RR, Heon E, Ritch R, Levin AV, Shields MB, Damji KF, Newlin A, Walter MA. Characterization and prevalence of pitx2 microdeletions and mutations in axenfeld-rieger malformations. Invest Ophthalmol Vis Sci. 2004; 45:828-33. [PMID: 14985297]
  9. Phillips JC, del Bono EA, Haines JL, Pralea AM, Cohen JS, Greff LJ, Wiggs JL. A second locus for rieger syndrome maps to chromosome 13q14. Am J Hum Genet. 1996; 59:613-9. [PMID: 8751862]
  10. Tanwar M, Dada T, Dada R. Axenfeld-rieger syndrome associated with congenital glaucoma and cytochrome p4501b1 gene mutations. Case Rep Med. 2010;
  11. Lehmann OJ, Sowden JC, Carlsson P, Jordan T, Bhattacharya SS. Fox's in development and disease. Trends Genet. 2003; 19:339-44. [PMID: 12801727]
  12. Descipio C, Schneider L, Young TL, Wasserman N, Yaeger D, Lu F, Wheeler PG, Williams MS, Bason L, Jukofsky L, Menon A, Geschwindt R, Chudley AE, Saraiva J, Schinzel AA, Guichet A, Dobyns WE, Toutain A, Spinner NB, Krantz ID. Subtelomeric deletions of chromosome 6p: Molecular and cytogenetic characterization of three new cases with phenotypic overlap with ritscher-schinzel (3c) syndrome. Am J Med Genet A. 2005; 134A:3-11. [PMID: 15704124]
  13. Gould DB, Jaafar MS, Addison MK, Munier F, Ritch R, MacDonald IM, Walter MA. Phenotypic and molecular assessment of seven patients with 6p25 deletion syndrome: Relevance to ocular dysgenesis and hearing impairment. BMC Med Genet. 2004; 5:17 [PMID: 15219231]
  14. Le Caignec C, De Mas P, Vincent MC, Boceno M, Bourrouillou G, Rival JM, David A. Subtelomeric 6p deletion: Clinical, fish, and array cgh characterization of two cases. Am J Med Genet A. 2005; 132A:175-80. [PMID: 15578619]
  15. Tümer Z, Bach-Holm D. Axenfeld-rieger syndrome and spectrum of pitx2 and foxc1 mutations. Eur J Hum Genet. 2009; 17:1527-39. [PMID: 19513095]
  16. Mears AJ, Jordan T, Mirzayans F, Dubois S, Kume T, Parlee M, Ritch R, Koop B, Kuo WL, Collins C, Marshall J, Gould DB, Pearce W, Carlsson P, Enerback S, Morissette J, Bhattacharya S, Hogan B, Raymond V, Walter MA. Mutations of the forkhead/winged-helix gene, fkhl7, in patients with axenfeld-rieger anomaly. Am J Hum Genet. 1998; 63:1316-28. [PMID: 9792859]
  17. Stathacopoulos RA, Bateman JB, Sparkes RS, Hepler RS. The rieger syndrome and a chromosome 13 deletion. J Pediatr Ophthalmol Strabismus. 1987; 24:198-203. [PMID: 3117999]
  18. Werner W, Kraft S, Callen DF, Bartsch O, Hinkel GK. A small deletion of 16q23.1→16q24.2 [del(16)(q23.1q24.2).Ish del(16)(q23.1q24.2)(d16s395+, d16s348-, p5432+)] in a boy with iris coloboma and minor anomalies. Am J Med Genet. 1997; 70:371-6. [PMID: 9182777]
  19. Hjalt TA, Semina EV. Current molecular understanding of axenfeld-rieger syndrome. Expert Rev Mol Med. 2005; 7:1-17. [PMID: 16274491]
  20. Saleem RA, Banerjee-Basu S, Berry FB, Baxevanis AD, Walter MA. Structural and functional analyses of disease-causing missense mutations in the forkhead domain of foxc1. Hum Mol Genet. 2003; 12:2993-3005. [PMID: 14506133]
  21. Kume T, Deng KY, Winfrey V, Gould DB, Walter MA, Hogan BL. The forkhead/winged helix gene mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus. Cell. 1998; 93:985-96. [PMID: 9635428]
  22. Pierrou S, Hellqvist M, Samuelsson L, Enerback S, Carlsson P. Cloning and characterization of seven human forkhead proteins: Binding site specificity and DNA bending. EMBO J. 1994; 13:5002-12. [PMID: 7957066]
  23. Nishimura DY, Searby CC, Alward WL, Walton D, Craig JE, Mackey DA, Kawase K, Kanis AB, Patil SR, Stone EM, Sheffield VC. A spectrum of foxc1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye. Am J Hum Genet. 2001; 68:364-72. [PMID: 11170889]
  24. Strungaru MH, Dinu I, Walter MA. Genotype-phenotype correlations in axenfeld-rieger malformation and glaucoma patients with foxc1 and pitx2 mutations. Invest Ophthalmol Vis Sci. 2007; 48:228-37. [PMID: 17197537]
  25. Mirza G, Williams RR, Mohammed S, Clark R, Newbury-Ecob R, Baldinger S, Flinter F, Ragoussis J. Refined genotype-phenotype correlations in cases of chromosome 6p deletion syndromes. Eur J Hum Genet. 2004; 12:718-28. [PMID: 15150541]
  26. Khan AO, Aldahmesh MA, Al-Amri A. Heterozygous foxc1 mutation (m161k) associated with congenital glaucoma and aniridia in an infant and a milder phenotype in her mother. Ophthalmic Genet. 2008; 29:67-71. [PMID: 18484311]
  27. Komatireddy S, Chakrabarti S, Mandal AK, Reddy AB, Sampath S, Panicker SG, Balasubramanian D. Mutation spectrum of foxc1 and clinical genetic heterogeneity of axenfeld-rieger anomaly in india. Mol Vis. 2003; 9:43-8. [PMID: 12592227]
  28. Saleem RA, Banerjee-Basu S, Berry FB, Baxevanis AD, Walter MA. Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein foxc1. Am J Hum Genet. 2001; 68:627-41. [PMID: 11179011]
  29. Wyatt A, Bakrania P, Bunyan DJ, Osborne RJ, Crolla JA, Salt A, Ayuso C, Newbury-Ecob R, Abou-Rayyah Y, Collin JR, Robinson D, Ragge N. Novel heterozygous otx2 mutations and whole gene deletions in anophthalmia, microphthalmia and coloboma. Hum Mutat. 2008; 29:E278-83. [PMID: 18781617]
  30. Shields MB. Axenfeld-rieger syndrome: A theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc. 1983; 81:736-84. [PMID: 6676983]